Outcome prediction in myelodysplastic neoplasm undergoing hematopoietic cell transplant in the molecular era of IPSS-M

Saved in:
Bibliographic Details
Published inLeukemia Vol. 37; no. 3; pp. 717 - 719
Main Authors Gurnari, Carmelo, Gagelmann, Nico, Badbaran, Anita, Awada, Hussein, Dima, Danai, Pagliuca, Simona, D’Aveni-Piney, Maud, Attardi, Enrico, Voso, Maria Teresa, Cerretti, Raffaella, Wolschke, Christine, Rubio, Marie Thérèse, Maciejewski, Jaroslaw P., Kröger, Nicolaus
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 01.03.2023
Nature Publishing Group
Subjects
692/499
692/699/1541/1990/1673
Bone marrow
Cancer Research
Confidence intervals
Critical Care Medicine
Cytogenetics
Hematology
Hematopoietic Stem Cell Transplantation
Hematopoietic stem cells
Humans
Intensive
Internal Medicine
Letter
Medicine
Medicine & Public Health
Myelodysplastic Syndromes - diagnosis
Myelodysplastic Syndromes - genetics
Myelodysplastic Syndromes - therapy
Neoplasms - diagnosis
Neoplasms - genetics
Neoplasms - therapy
Oncology
Prognosis
Retrospective Studies
Stem cell transplantation
Treatment Outcome
Tumors
Online AccessGet full text

Cover

More Information
Bibliography:SourceType-Other Sources-1
ObjectType-Article-1
content type line 63
ObjectType-Correspondence-2
AUTHOR CONTRIBUTIONS
CG, NG, JPM and NK generated and conceived the study design, figures, tables and wrote the manuscript; NG performed data analysis. AB, HA, DD, SP, MD’A-P, EA, MTV, RC, CW, MTR, reviewed the clinical data, took part in patient selection and helped editing the manuscript. All authors participated in data interpretation and critical review of the final paper and submission.
ISSN:0887-6924
1476-5551
DOI:10.1038/s41375-023-01820-4